18 January 2019 - - US-based commercial-stage biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has finalised its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy following a recent meeting with the US Food and Dru...
18 January 2019 - - US-based biopharmaceutical company Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) has completed patient dosing in the company's TIME-2b study, a Phase 2b clinical trial designed to assess the efficacy and safety of Aerpio's...
18 January 2019 - - A new paper in Science Translational Medicine showcases the discovery and development of TTP399, an investigational, oral, small molecule, liver-selective glucokinase activator, as a potential treatment for diabetes, the...
18 January 2019 - - The Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's Vizimpro (dacomitinib) for EGFR gene mutation-positive, i...
18 January 2019 - Biotechnology company Spectrum Pharmaceuticals Inc (NASDAQ-GS:SPPI) revealed on Thursday the launch of a definitive agreement to divest its portfolio of seven products to Acrotech Biopharma LLC, a New Jersey-based wholly-owned subsi...